Benitec Biopharma Inc. (BNTC) Financial Statements (2024 and earlier)

Company Profile

Business Address 3940 TRUST WAY
HAYWARD, CA 94545
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
6/30/2023
12/31/2022
MRQ
6/30/2022
6/30/2021
6/30/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,47710,5374,06219,7699,801
Cash and cash equivalents2,47710,5374,06219,7699,801
Restricted cash and investments131414  
Receivables     59
Other current assets     949
Other undisclosed current assets1,239424744839 
Total current assets:3,72910,9754,82020,60810,809
Noncurrent Assets
Operating lease, right-of-use asset526650771202395
Property, plant and equipment87139222375374
Other noncurrent assets97116135185 
Other undisclosed noncurrent assets25252599
Total noncurrent assets:7359301,153771778
TOTAL ASSETS:4,46411,9055,97321,37911,587
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7569681,424737890
Employee-related liabilities400276203
Accounts payable1,140531422274282
Accrued liabilities616437602187405
Other undisclosed current liabilities2,2221,5211,108632246
Total current liabilities:3,9782,4892,5321,3691,136
Noncurrent Liabilities
Long-term debt and lease obligation:   559 213
Liabilities, other than long-term debt284422   
Operating lease, liability284422559 213
Other undisclosed noncurrent liabilities   (559) (213)
Total noncurrent liabilities:284422559 213
Total liabilities:4,2622,9113,0911,3691,349
Equity
Equity, attributable to parent2028,9942,88220,01010,238
Common stock  3111
Additional paid in capital168,921168,720152,453151,583128,826
Accumulated other comprehensive loss(830)(898)(1,245)(1,455)(1,953)
Accumulated deficit(167,889)(158,831)(148,327)(130,119)(116,636)
Total equity:2028,9942,88220,01010,238
TOTAL LIABILITIES AND EQUITY:4,46411,9055,97321,37911,587

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
6/30/2023
12/31/2022
TTM
6/30/2022
6/30/2021
6/30/2020
Revenues75627359102
Gross profit:75627359102
Operating expenses(19,156)(18,450)(17,927)(13,655)(8,383)
Operating loss:(19,081)(18,388)(17,854)(13,596)(8,281)
Nonoperating income (expense)(481)(458)(354)(286)7
Gain (loss), foreign currency transaction, before tax(415)(385)(232)(333)(88)
Other nonoperating income (expense)(30)(29)(79)3734
Loss from continuing operations:(19,562)(18,846)(18,208)(13,882)(8,274)
Loss before gain (loss) on sale of properties:(13,435)(18,208)(13,882)(8,274)
Net loss available to common stockholders, diluted:(19,562)(18,846)(18,208)(13,882)(8,274)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
6/30/2023
12/31/2022
TTM
6/30/2022
6/30/2021
6/30/2020
Net loss:(19,562)(18,846)(18,208)(13,882)(8,274)
Comprehensive loss:(19,562)(18,846)(18,208)(13,882)(8,274)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent415375210498(89)
Comprehensive loss, net of tax, attributable to parent:(19,147)(18,471)(17,998)(13,384)(8,363)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: